Editorial Oncomology Platform and Utility Protocols (Q11677)

From EU Knowledge Graph
Revision as of 09:34, 22 September 2020 by DG Regio (talk | contribs) (‎Removed claim: EU contribution (P835): 1,592,180.4524 euro)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Editorial Oncomology Platform and Utility Protocols
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    0 references
    39,804,511.31 Czech koruna
    0 references
    61,769,881.0 Czech koruna
    0 references
    2,470,795.24 Euro
    10 January 2020
    0 references
    64.44 percent
    0 references
    31 October 2020
    0 references
    Institute of Applied Biotechnologies a.s.
    0 references

    50°5'1.93"N, 14°30'28.48"E
    0 references
    10800
    0 references
    10800
    0 references
    Jedná se o projekt vysoké technologické úrovně a vysoké míry inovace, který si klade za cíl významně zvýšit produktový potenciál společnosti Institute of Applied Biotechnologies a.s. (IAB) ve spolupráci s výzkumným partnerem Lékařskou fakultou Univerzity Palackého v Olomouci, jmenovitě Ústavem molekulární a translační medicíny (UMTM). Cílem je vývoj produktů pro prediktivní onkologickou diagnostiku založenou na cirkulujících buňkách / DNA / RNA. a. (Czech)
    0 references
    It is a project of high technological level and a high level of innovation which aims to significantly increase the product potential of the Institute of Applied Biotechnologies a.s. (IAB) in cooperation with the research partner of the Faculty of Medicine of Palacký University in Olomouc, namely the Institute of Molecular and Translation Medicine (UMTM). The objective is the development of products for predictive cancer diagnostics, based on circulating cell cells/DNA/RNA. a. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_107/0012422
    0 references